Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 111 of the 120 references it cites were found in a registry or an index; 42 of the 153 sources its claims cite were checked for support.

Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials

Open access
Sweetman, Alexander, Lack, Leon, Bastien, Célyne · 2019 · Brain Sciences

Abstract

Co-morbid insomnia and sleep apnea (COMISA) is a highly prevalent and debilitating disorder, which results in additive impairments to patients’ sleep, daytime functioning, and quality of life, and complex diagnostic and treatment decisions for clinicians. Although the presence of COMISA was first recognized by Christian Guilleminault and colleagues in 1973, it received very little research attention for almost three decades, until the publication of two articles in 1999 and 2001 which collectively reported a 30%–50% co-morbid prevalence rate, and re-ignited research interest in the field. Since 1999, there has been an exponential increase in research documenting the high prevalence, common characteristics, treatment complexities, and bi-directional relationships of COMISA. Recent trials indicate that co-morbid insomnia symptoms may be treated with cognitive and behavioral therapy for insomnia, to increase acceptance and use of continuous positive airway pressure therapy. Hence, the treatment of COMISA appears to require nuanced diagnostic considerations, and multi-faceted treatment approaches provided by multi-disciplinary teams of psychologists and physicians. In this narrative review, we present a brief overview of the history of COMISA research, describe the importance of measuring and managing insomnia symptoms in the presence of sleep apnea, discuss important methodological and diagnostic considerations for COMISA, and review several recent randomized controlled trials investigating the combination of CBTi and CPAP therapy. We aim to provide clinicians with pragmatic suggestions and tools to identify, and manage this prevalent COMISA disorder in clinical settings, and discuss future avenues of research to progress the field. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.

Overview

CoChat Summary

TL;DR

COMISA is a common co-morbidity of insomnia and obstructive sleep apnea, associated with worse sleep, daytime functioning, and quality of life than either disorder alone. This narrative review argues that COMISA should be actively screened for and treated with combined CBTi and CPAP, while noting that the best sequencing and measurement approaches still need refinement.

Key findings

  • The paper states COMISA prevalence is commonly in the range of 30%–50%; earlier studies reported 43% of 80 insomnia patients had AHI ≥ 5 and 29% had AHI ≥ 15, while 50% of 231 OSA patients reported clinically significant insomnia symptoms.
  • A 2010 review cited in the paper concluded 39%–58% of OSA patients report insomnia symptoms, and 29%–67% of insomnia patients meet minimal OSA criteria; a later meta-analysis of 37 studies reported 35% of insomnia patients had AHI ≥ 5, 29% had AHI ≥ 15, and 38% of OSA patients met insomnia criteria.
  • The review says COMISA patients have greater impairment in sleep, daytime functioning, depressive/psychiatric symptoms, and quality of life than patients with insomnia or OSA alone, and are also more likely to have reduced CPAP acceptance and use.
  • Recent randomized controlled trials reported that CBTi improved insomnia outcomes in COMISA and, in some studies, increased CPAP use by 78 min at 3 months and 48 min at 6 months, or by 61 min at 6 months; another study reported 57 min and 64 min greater CPAP use at 3 and 6 months, respectively.

Methods

  • Narrative review of COMISA research, covering prevalence, consequences, measurement issues, treatment approaches, bidirectional mechanisms, and recent randomized controlled trials.
  • Synthesizes prior studies and recent RCTs; the text specifically discusses studies of 56, 80, 231, 134, 121, 125, 145, and 630 participants, depending on the cited study.
  • Main analytic approach is qualitative synthesis of published evidence rather than a new empirical analysis.

Limitations

  • Stated in the paper: there has been a lack of research attention to COMISA for long periods, and there is still a need to validate and refine insomnia measures in the presence of OSA.
  • Stated in the paper: the available RCTs give only tentative support for CBTi/CPAP sequencing, and the paper notes that more data are needed to confirm which treatment sequence is best.
  • Evident from the text: this is a narrative review, so conclusions depend on heterogeneous prior studies with varying definitions of insomnia, OSA, populations, and outcomes; the paper itself notes that prevalence estimates vary considerably by criteria and sample.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/brainsci9120371

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 History of research in co-morbid insomnia and sleep apnea, including Guilleminault and colleague’s 1973 article, and a lack of widespread research attention until two articles by Lichstein and colleagues (1999) and Krakow and colleagues (2001).
Figure 1 History of research in co-morbid insomnia and sleep apnea, including Guilleminault and colleague’s 1973 article, and a lack of widespread research attention until two articles by Lichstein and colleagues (1999) and Krakow and colleagues (2001).CC BY · PubMed Central

Verification

Claims the paper makes

31 Valid · 2 Not valid · 46 Not checked · 25 Own results and interpretations

51 more claims · 9 with their cited sources checked

Create a free account to see all 104 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 41
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 120 references

Research works printed but not linked: 3

  1. Lichstein, K., McCrae, C., and Wilson, N. (2003). Secondary insomnia: Diagnostic issues, cognitive-behavioral treatment, and future directions. Treating Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine, Wiley.
  2. Smith, 2009, Sleep onset insomnia is associated with reduced adherence to CPAP therapy, Sleep Biol. Rhythm., 7, 74
  3. Parikh, 2011, 36 Hours of Sleep Deprivation Reduces Genioglossus Muscle Activity during Hypercapnia and Inspiratory Resistive Loads during Wakefulness, Sleep, 34, A153

Cited by

See all 253

Metadata

Authors
Sweetman, A., Lack, L., & Bastien, C.
Affiliations
  • Flinders University (AU)
  • Université Laval (CA)
Corresponding author
Sweetman, Alexander
Venue
Brain Sciences
Publisher
MDPI AG
Published
2019-12-12
Volume
9
Issue
12
Pages
371
ISSN
2076-3425 (ISSN-L)
OpenAlex
W2995714602
Cited by
253
References
120
Citations by year
2026: 46 · 2025: 47 · 2024: 38 · 2023: 47 · 2022: 26 · 2021: 34 · 2020: 13
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
Keywords
insomnia, sleep apnea, comorbidities, prevalence, cognitive behavioral therapy for insomnia, continuous positive airway pressure, CPAP acceptance, sleep quality, daytime functioning, quality of life, diagnosis, interdisciplinary treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials. https://app.cochat.ai/papers/10.3390/brainsci9120371
The paper
Sweetman, A., Lack, L., & Bastien, C. (2019). Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials. Brain Sciences. https://doi.org/10.3390/brainsci9120371

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.